Patents
Patents for C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups (15,621)
03/2003
03/13/2003WO2003020685A1 Fluorine compound and fluorinating agent comprising the compound
03/13/2003WO2003020684A1 (alpha)-haloenamine reagents
03/13/2003WO2002097050A3 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions
03/13/2003WO2002053519A3 Hydrophobic polyamine analogs and methods for their use
03/13/2003WO2002050019A3 Diamines as modulators of chemokine receptor activity
03/13/2003US20030049310 Genetic enginnering; inducing antibodies
03/13/2003CA2458859A1 (alpha)-haloenamine reagents
03/12/2003EP1289940A2 Excitatory amino acid receptor modulators
03/12/2003EP1289939A1 Phenylglycine derivatives
03/12/2003EP1289934A1 Method for producing amides or esters
03/12/2003CN1402703A Tri-substd. phenyl derivs. and analogues
03/12/2003CN1401629A Image forming agent, its precursor and preparing process thereof
03/11/2003US6531610 Intermediate acylating carbonate
03/11/2003US6531495 Potassium channel
03/07/2003WO2002020472A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
03/07/2003CA2421781A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
03/06/2003WO2003018552A2 Aromatic and heteroaromatic acid halides for synthesizing polyamides
03/06/2003WO2003018542A1 Novel norstatin derivative
03/06/2003WO2003018538A1 Novel diarylalkene derivatives and novel diarylalkane derivatives
03/06/2003WO2003018535A2 Novel aminobenzoephenones
03/06/2003WO2002085877A3 Processes and intermediates for preparing benzyl substituted epoxides
03/06/2003WO2002066415A8 Non-steroidal modulators of estrogen receptors
03/06/2003US20030045743 Using chromatographic process for separating a target chiral compound from its enantiomer in a racemic mixtures; purification
03/06/2003US20030045730 Process for preparation of optically active n-substituted azetidine-2-carboxylic acids
03/06/2003US20030045579 Compounds and compositions for delivering active agents
03/06/2003US20030045574 Such as alpha-phenyl-N-(7-tert-butoxycarbonylamino-3,5-dimethyladamantane)nitrone for treatment of neurological/ inflammatory diorders, and aging, which result from the overproduction of nitric oxide
03/06/2003CA2458616A1 Aromatic and heteroaromatic acid halides for synthesizing polyamides
03/05/2003EP1287404A1 Method for immobilizing oligonucleotides employing the cycloaddition bioconjugation method
03/05/2003EP1287053A1 Urethane based on organoleptically active aromatic alcohols
03/05/2003EP1287006A1 Antitumoral compounds
03/05/2003EP1286967A1 Cyclohexane derivatives and their use as therapeutic agents
03/05/2003EP1286957A1 Diphenylmethane derivatives
03/05/2003EP0942901B1 Cyclic imines as pesticides
03/05/2003CN1400969A Fused imidazolium derivatives
03/04/2003US6528678 Phosgene-free process for preparing carbamates
03/04/2003US6528675 Cyanohydrin ethers and esters as high-sensitivity enzyme substrates
03/04/2003US6528499 Ligands for metabotropic glutamate receptors and inhibitors of NAALADase
02/2003
02/27/2003WO2002068592A3 Non-racemic hexafluoreleucine, and methods of making and using it
02/27/2003WO2002066420A3 Tryptase inhibitors
02/26/2003EP1285651A1 Melanin concentrating hormone antagonists
02/26/2003EP1285018A2 Monofunctional monomers, radically polymerisable compositions containing them and resins and ophthalmic articles obtained from them,
02/26/2003EP1284960A1 Cyclic amino acid derivatives useful as pharmaceutical agents
02/26/2003EP1284959A1 Compounds for modulating the rage receptor
02/26/2003EP1284724A1 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
02/25/2003US6525220 Intermediates for the synthesis of benzimidazole derivatives and a process for the preparation thereof
02/25/2003US6525199 Ring coupling, reduction and deprotecting; synthesis of compounds for alleviation and treatment of symptoms due to ischemic diseases
02/25/2003US6525068 Hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand
02/25/2003US6525020 For drug delivery
02/20/2003WO2003014102A1 Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors
02/20/2003WO2003014076A2 Bi-directional synthesis of oligoguanidine transport agents
02/20/2003WO2003014069A1 Fluoro linkers and their use as linkers for enzyme-activated drug conjugates
02/20/2003WO2003013502A1 Compounds which mimic the chemical and biological properties of discodermolide
02/20/2003WO2002088069A3 Compounds useful as intermediates for 4-aminoquinoline derivatives
02/20/2003WO2002048097B1 Compounds, compositions and methods for treatment of parasitic infections
02/20/2003CA2456553A1 Compounds which mimic the chemical and biological properties of discodermolide
02/20/2003CA2455951A1 Bi-directional synthesis of oligoguanidine transport agents
02/20/2003CA2454081A1 Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors
02/20/2003CA2453245A1 Fluoro linkers and their use as linkers for enzyme-activated drug conjugates
02/19/2003EP1284145A1 2-(3,4-Dihydroxyphenyl)ethyl substituted carbonic acid derivatives and their use
02/19/2003EP1144360A4 A method for the synthesis of compounds of formula 1 and derivatives thereof
02/19/2003CN1398247A Colchinol derivatives as vascular damaging agents
02/19/2003CN1101808C Method for producing organic diurethanes and/or polyurethanes and their usein prodn. of di-and/or polyisocyanates
02/18/2003US6521797 Precursors for organoleptic compounds, especially for flavors, fragrances and masking agents, and/or antimicrobial compounds; 2,6-dimethyl-oct-5-enal generated by the cleavage of the oxime derivative
02/18/2003US6521666 Inhibitors of α4 mediated cell adhesion
02/18/2003US6521432 Methods for enhancing the rate of modification of metastable bonds
02/18/2003CA2073042C Phenylethanolamines, drugs containing these compounds, and a method of preparing them
02/17/2003CA2398112A1 2-(3,4-dihydroxyphenyl)ethyl-substituted carbonic acid derivatives and their use
02/13/2003WO2003011799A1 Kinetic resolutions of chirat 3- and 3-substituted carboxylic acids
02/13/2003WO2002088125A3 Triazolopyrimidines having a fungicidal effect
02/13/2003WO2002076995A3 2-amino-propanol derivatives
02/13/2003US20030032834 Aminoalcohol derivatives
02/13/2003US20030032644 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
02/13/2003US20030032641 Certain salts of discodermolide acid, pharmaceutical compositions containing them and their use in treating tumors
02/12/2003EP1282601A1 Process and intermediates for the preparation of 1-(9h-carbazol-4-yloxy)-3-[2-(2-methoxy-phenoxy)-ethylamino]-propan-2-ol, carvedilol or acid addition salt thereof
02/12/2003EP1282594A1 Branched amino acids
02/12/2003EP1150942A4 Improved compounds for protein binding
02/12/2003CN1101386C Trisubsted phenyl derivitives
02/11/2003US6518305 Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
02/11/2003US6518283 Squaric acid derivatives
02/11/2003US6518267 Protease inhibitors
02/11/2003US6518048 Hydrogenation a isophthalic acid derivative
02/06/2003WO2003010148A1 Pyrazoline derivatives and their use as pesticides
02/06/2003WO2003010134A1 Method for the production of 1,2,4-triaminobenzolecarbamic acid esters
02/06/2003WO2003010130A1 Amino acid derivatives
02/06/2003WO2003010089A1 Method for obtaining an ammonium carbamate solution from a gas mixture containing nh3, h2o and co2
02/06/2003WO2002032871A3 Compounds and methods for treating multidrug resistance
02/06/2003US20030028047 Esters of fatty acids and juvenoid alcohols, and a method of their preparation and use
02/06/2003US20030027862 Amino-and amido-diphenyl ethers
02/06/2003US20030027859 3-aryl-2-hydroxypropionic acid derivative I
02/06/2003US20030027821 Administering 2-oxy substituted benzoxazin-5-one derivative to a human or animal for the prevention or treatment of obesity or an obesity related disorder
02/06/2003CA2454168A1 Method for obtaining an ammonium carbamate solution from a gas mixture containing nh3, h2o and co2
02/05/2003EP1280765A2 Fluorous tagging compounds and their use
02/05/2003EP1280764A2 Inhibitors of histone deacetylase
02/05/2003EP1280757A2 New gamma selective retinoids
02/05/2003EP1082121A4 Hiv integrase inhibitors
02/05/2003CN1395557A Method for producing aryl-iminomethyl-carbamic acid esters
02/05/2003CN1394855A Substituted heterocyclic compound
02/04/2003US6515179 Process for the removal of nitrobenzenesulfonyl
02/04/2003US6515162 Method of preparing retroviral protease inhibitor intermediates
02/04/2003US6515151 Method for the preparation of novel sidechain-bearing taxanes and intermediates thereof
1 ... 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 ... 157